ZARZA We are Zarza, the prestigious firm behind major projects in information technology.
Listen "Lead: Alcohol Use Disorder Medication Coverage and Utilization Management in Medicaid Managed Care Plans"
Episode Synopsis
Alcohol Use Disorder Medication Coverage and Utilization Management in Medicaid Managed Care Plans
JAMA Network Open
This cross-sectional study examined how Medicaid managed care plans (MCPs) cover and manage medications for alcohol use disorder (AUD). A content analysis of publicly available data from all 241 comprehensive Medicaid MCPs in 2021 revealed that 103 plans (42.7%) covered all approved medications (acamprosate, naltrexone, and disulfiram) for AUD. Prior authorization and quantity limits were used rarely, except for injectable naltrexone. This study suggests that expanding medication use for AUD and providing patient-centered care may be undermined by insurance coverage limitations.
Read this issue of the ASAM Weekly
Subscribe to the ASAM Weekly
Visit ASAM
JAMA Network Open
This cross-sectional study examined how Medicaid managed care plans (MCPs) cover and manage medications for alcohol use disorder (AUD). A content analysis of publicly available data from all 241 comprehensive Medicaid MCPs in 2021 revealed that 103 plans (42.7%) covered all approved medications (acamprosate, naltrexone, and disulfiram) for AUD. Prior authorization and quantity limits were used rarely, except for injectable naltrexone. This study suggests that expanding medication use for AUD and providing patient-centered care may be undermined by insurance coverage limitations.
Read this issue of the ASAM Weekly
Subscribe to the ASAM Weekly
Visit ASAM
In God we trust